Tag: entrepreneurs
-
Biomarker-Guided Depression Drug Trial Underway
The first participant in a clinical trial received an experimental drug to treat patients with depression that express high levels of a stress-related protein.
-
Mental Health Therapy, Tech Network Gains Early Funds
A company building a therapy and technology network for improving access to mental health providers is raising $15 million in its first venture round.
-
Residual Cancer Detection Company Launches, Raises $56M
A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds.
-
Company to Boost Orphan Drugs in Europe
A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe.
-
Infographic – US, China Lead in Space Investments
Data collected by Space Capital, a venture investor in companies developing space-based technologies, shows $265 billion invested in these start-up companies since 2014.
-
Health Insurance for Small Business Employees
Small businesses that offer health insurance to their workers have an easier time attracting and retaining top talent.
-
Patent Awarded for Focused Ultrasound Skin Treatments
A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology.
-
Cancer Detection Start-Up Gains $4M in Seed Funds
A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round.
-
Gut-Brain Meds Developer Going Public in Merger
31 Oct. 2022. A developer of synthetic biology treatments for inflammatory and neurological disorders linked to the gut is becoming a public company through a special acquisition merger. Intrinsic Medicine Inc. in Seattle is joining with Phoenix Biotech Acquisition Corp. in Oakland, California, a special purpose acquisition company or SPAC, in a deal expected to…
-
Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment.